Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam versus nortriptyline for chronic migraine
IRCT20250713066468N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in chronic migraine comparing Levetiracetam with Nortriptyline control (2 arms). Primary endpoints: Number of attacks, Severity of attacks and 1 more. Started Aug 2025; status: completed.
02
Drugs
levetiracetamnortriptyline
03
Conditions
chronic migraine
Beyond the preview
Go deeper on IRCT20250713066468N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250713066468N1.